BMCI is trading at 569.90 as of the 21st of November 2024, a 0.02 percent decrease since the beginning of the trading day. The stock's open price was 570.0. BMCI has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for BMCI are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of May 2024 and ending today, the 21st of November 2024. Click here to learn more.
Although BMCI's alpha and beta are two of the key measurements used to evaluate BMCI's performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BMCI stock to make a market-neutral strategy. Peer analysis of BMCI could also be used in its relative valuation, which is a method of valuing BMCI by comparing valuation metrics with similar companies.